| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Surgimate is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Seasons Hospice & Palliative Care (SHPC) is a community-based organization with an ongoing mission to find creative solutions that add quality to end-of-life care. The caregivers at SHPC hold steadfast to the patient/family focus of hospice care. We recognize that individuals and families are the experts in their own care, and we continuously strive for excellence beyond accepted standards. We are born into a world of comfort, warmth and love, and it our belief that we should all leave this world in the same way. To further that goal, we work with communities to increase the awareness of hospice as part of the continuum of care.
Olympic Medical Corp is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Goddard USD is a Goddard, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.